Sector valuations Charles River Laboratories International, Inc. Deutsche Boerse AG
Stocks
RV6
US1598641074
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.42 EUR | -1.43% |
|
+0.86% | +16.06% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 34.53x | 4.38x | 1.49x | 6.07x | 18.77x | 26.05x | 0.95% | 49.74B | ||
| -23.85x | 18.75x | -0.7x | 349.22x | -22.56x | -21.84x | -.--% | 40.49B | ||
| 47.3x | 6.92x | 0.3x | 4.68x | 29.91x | 35.32x | -.--% | 34.35B | ||
| 25.34x | 4.8x | 5.26x | 2.8x | 12.11x | 18.45x | -.--% | 34.75B | ||
| 27.63x | 2.19x | 0.61x | 7.94x | 19.87x | 23.06x | 0.41% | 26.98B | ||
| 32.22x | 16.06x | 2.94x | 5.2x | 23.7x | 24.85x | -.--% | 15.6B | ||
| -24.06x | 356.54x | -0.47x | 15.69x | -23.46x | -22.55x | -.--% | 14.27B | ||
| 23.93x | 2.51x | 0.82x | 2.04x | 8.96x | 14.17x | 1.12% | 13.76B | ||
| 23.88x | 1.33x | 0.17x | 1.9x | 11.51x | 13.07x | -.--% | 12.92B | ||
| -34.69x | 10.52x | 1.43x | 133.33x | -37.95x | -66.04x | -.--% | 12.49B | ||
| 60.61x | 5.07x | 0.4x | 9.05x | 25.71x | 28.1x | 0.45% | 11B | ||
| -30.08x | 26.63x | -0.72x | 7.17x | 176.13x | -552.31x | -.--% | 10.79B | ||
| -30.94x | 8.95x | -13.59x | 993.2x | -26.33x | -25.8x | -.--% | 10.01B | ||
| -33.85x | 8.72x | 7.47x | 100.27x | -22.5x | -21.69x | -.--% | 9.81B | ||
| -144.19x | 4.99x | 1.14x | 5.62x | 29.8x | 170.38x | -.--% | 9.2B | ||
| -21.31x | 8.06x | -1.66x | 2485.85x | -18.02x | -17.12x | -.--% | 9.03B | ||
| 35.97x | - | -0.12x | 16.63x | 29.69x | 32.16x | -.--% | 9.06B | ||
| 18.03x | 2.1x | 1.68x | 4.01x | 10.61x | 13.77x | -.--% | 8.01B | ||
| Average | -0.75x | 28.74x | 0.36x | 230.59x | 13.66x | -18.22x | 0.16% | 18.46B | |
| Weighted average by Cap. | 9.08x | 23.56x | 0.81x | 152.66x | 12.04x | -5.46x | 0.24% |
Select your edition
All financial news and data tailored to specific country editions
















